Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada
· Delayed Price · Currency is CAD 0.1300
-0.0050 (-3.70%)
May 12, 2025, 3:13 PM EDT
Ventripoint Diagnostics Revenue
In the year 2024, Ventripoint Diagnostics had annual revenue of 95.17K CAD with 93.51% growth.
Revenue
95.17K
Revenue Growth
+93.51%
P/S Ratio
222.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
21.22M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.58B |
| Sienna Senior Living | 896.45M |
| Extendicare | 1.47B |
| Trulieve Cannabis | 1.71B |
| Cronos Group | 179.08M |
| WELL Health Technologies | 919.69M |
| Curaleaf Holdings | 1.89B |
Ventripoint Diagnostics News
- 12 days ago - Ventripoint Expands Advisory Board with addition of Ultrasound AI Executive - TheNewswire
- 4 weeks ago - Ventripoint Provides Corporate Update and Announces Shareholder Teleconference - TheNewswire
- 4 weeks ago - Ventripoint Appoints Nicolas Coutin to Oversee Clinical Affairs - TheNewswire
- 5 weeks ago - Ventripoint Makes Application to Amend Warrants - TheNewswire
- 7 weeks ago - Ventripoint Diagnostics Publishes Whitepaper on the Use of AI in Whole-Heart Analysis - TheNewswire
- 7 weeks ago - Ventripoint Announces Closing of $500,000 Non-Brokered Convertible Debenture Unit Private Placement - TheNewswire
- 2 months ago - Ventripoint Announces Non-Brokered Convertible Debenture Units Private Placement - TheNewswire
- 2 months ago - Ventripoint Diagnostics Announces U.S. FDA 510(k) Clearance for VMS+(TM) 4.0 Automated Radiological Image Processing Software/System - TheNewswire